1. Extended Surgical Resection and Histology in Retroperitoneal Sarcoma

   • Aimee M. Crago

   Bone and Soft Tissue Sarcomas 15 October 2014 Pages: 1401 - 1403

   

2. Implications of HER2-Targeted Therapy on Extent of Surgery for Early-Stage Breast Cancer

   • Hamza Aziz
   • P. Kelly Marcom
   • E. Shelley Hwang

   Breast Oncology 17 March 2015 Pages: 1404 - 1405

3. Spotlight on Neoadjuvant Therapy for Breast Cancer

   • Judy C. Boughey
   • Kelly K. Hunt

   Breast Oncology 02 March 2015 Pages: 1406 - 1407

4. Landscape of Neoadjuvant Therapy for Breast Cancer

   • Tufia C. Haddad
   • Matthew P. Goetz

   Breast Oncology 02 March 2015 Pages: 1408 - 1415

5. Role of Imaging in Neoadjuvant Therapy for Breast Cancer

   • Vandana Dialani
   • Tamuna Chadashvili
   • Priscilla J. Slanetz

   Breast Oncology 02 March 2015 Pages: 1416 - 1424

   

6. Impact of Neoadjuvant Chemotherapy on Locoregional Surgical Treatment of Breast Cancer

   • Eleftherios P. Mamounas

   Breast Oncology 02 March 2015 Pages: 1425 - 1433

7. Influence of Neoadjuvant Chemotherapy on Radiotherapy for Breast Cancer

   • Amit K. Garg
   • Thomas A. Buchholz

   Breast Oncology 02 March 2015 Pages: 1434 - 1440

   

8. Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer

   • Patricia Cortazar
   • Charles E. Geyer Jr.

   Breast Oncology 02 March 2015 Pages: 1441 - 1446

9. Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection

   • Alessandro Gronchi
   • Rosalba Miceli
   • Sylvie Bonvalot

   Bone and Soft Tissue Sarcomas 10 October 2014 Pages: 1447 - 1454

   

10. Safety and Efficacy of Radiation Dose Delivered via Iodine-125 Brachytherapy Mesh Implantation for Deep Cavity Sarcomas

    • Mark Fairweather
    • Jiping Wang
    • Chandrajit P. Raut

    Bone and Soft Tissue Sarcomas 24 October 2014 Pages: 1455 - 1463

    

11. Prognostic Value of CTNNB1 Gene Mutation in Primary Sporadic Aggressive Fibromatosis

    • Danique L. M. van Broekhoven
    • Cornelis Verhoef
    • Thijs van Dalen

    Bone and Soft Tissue Sarcomas 24 October 2014 Pages: 1464 - 1470

    

12. Patients with Invasive Lobular Breast Cancer Are Less Likely to Undergo Breast-Conserving Surgery: A Population Based Study in The Netherlands

    • W. Truin
    • R. M. Roumen
    • A. C. Voogd

    Breast Oncology 17 October 2014 Pages: 1471 - 1478

    

13. Papilloma on Core Biopsy: Excision vs. Observation

    • Faina Nakhlis
    • Nasim Ahmadiyeh
    • Mehra Golshan

    Breast Oncology 01 November 2014 Pages: 1479 - 1482

14. Assessing Localized Skin-to-Fat Water in Arms of Women with Breast Cancer Via Tissue Dielectric Constant Measurements in Pre- and Post-surgery Patients

    • Harvey N. Mayrovitz
    • Daniel N. Weingrad
    • Lidice Lopez

    Breast Oncology 12 November 2014 Pages: 1483 - 1489

    

15. Do MRI and Mammography Reliably Identify Candidates for Breast Conservation After Neoadjuvant Chemotherapy?

    • Maxine S. Jochelson
    • Katharine Lampen-Sachar
    • Monica Morrow

    Breast Oncology 17 March 2015 Pages: 1490 - 1495

    

16. Prokineticin 1 Protein Expression is a Useful New Prognostic Factor for Human Sporadic Colorectal Cancer

    • Toshiyuki Nakazawa
    • Takanori Goi
    • Akio Yamaguchi

    Colorectal Cancer 21 October 2014 Pages: 1496 - 1503

    

17. Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis

    • Hideki Ueno
    • Eiji Shinto
    • Kazuo Hase

    Colorectal Cancer 14 November 2014 Pages: 1504 - 1512

    

18. Prognostic Significance of the Lymph Node Ratio in Stage IV Colorectal Cancer Patients who have Undergone Curative Resection

    • Tsuyoshi Ozawa
    • Soichiro Ishihara
    • Toshiaki Watanabe

    Colorectal Cancer 15 November 2014 Pages: 1513 - 1519

    

19. Incorporation of Radiotherapy in the Multidisciplinary Treatment of Isolated Retroperitoneal Lymph Node Recurrence from Colorectal Cancer

    • Jeongshim Lee
    • Jee Suk Chang
    • Woong Sub Koom

    Colorectal Cancer 15 January 2015 Pages: 1520 - 1526

    

20. A Risk Model to Determine Surgical Treatment in Patients with Thyroid Nodules with Indeterminate Cytology

    • Carlos Aitor Macias
    • Dena Arumugam
    • Stanley Z. Trooskin

    Endocrine Tumors 12 November 2014 Pages: 1527 - 1532

    

21. Multidisciplinary Cancer Conferences for Gastrointestinal Malignancies Result in Measureable Treatment Changes: A Prospective Study of 149 Consecutive Patients

    • Jacqueline Oxenberg
    • Wesley Papenfuss
    • Valerie Francescutti

    Gastrointestinal Oncology 17 October 2014 Pages: 1533 - 1539

22. A Nationwide Retrospective Study of Perioperative Chemotherapy for Gastroesophageal Adenocarcinoma: Tolerability, Outcome, and Prognostic Factors

    • Anders Christian Larsen
    • Cecilie Holländer
    • Morten Ladekarl

    Gastrointestinal Oncology 28 October 2014 Pages: 1540 - 1547

    

23. Carbon Dioxide Pneumoperitoneum Led to No Severe Morbidities for the Elderly During Laparoscopic-Assisted Distal Gastrectomy

    • Satoshi Suzuki
    • Tetsu Nakamura
    • Yoshihiro Kakeji

    Gastrointestinal Oncology 14 November 2014 Pages: 1548 - 1554

    

24. Safety, Efficacy, and Long-Term Follow-Up Evaluation of Perioperative Epirubicin, Cisplatin, and Capecitabine Chemotherapy in Esophageal Resection for Adenocarcinoma

    • P. C. van der Sluis
    • I. Ubink
    • R. van Hillegersberg

    Gastrointestinal Oncology 07 January 2015 Pages: 1555 - 1563

    

25. Can a Sentinel Node Mapping Algorithm Detect All Positive Lymph Nodes in Cervical Cancer?

    • Rosyane Rena de Freitas
    • Glauco Baiocchi
    • Ademar Lopes

    Gynecologic Oncology 18 November 2014 Pages: 1564 - 1569

26. Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

    • J. Spiliotis
    • E. Halkia
    • S. Giassas

    Gynecologic Oncology 13 November 2014 Pages: 1570 - 1575

    

27. Hepatic Vein-Sparing Hepatectomy for Multiple Colorectal Liver Metastases at the Caval Confluence

    • Guido Torzilli
    • Fabio Procopio
    • Carlos A. Garcia-Etienne

    Original Article –Hepatobiliary Tumors 29 October 2014 Pages: 1576 - 1576

28. Mortality in Emergency Surgical Oncology

    • M. R. F. Bosscher
    • B. L. van Leeuwen
    • H. J. Hoekstra

    Healthcare Policy and Outcomes 25 October 2014 Pages: 1577 - 1584

    

29. Is Complete Liver Resection Without Resection of Synchronous Lung Metastases Justified?

    • Yoshihiro Mise
    • Scott Kopetz
    • Jean-Nicolas Vauthey

    Hepatobiliary Tumors 06 November 2014 Pages: 1585 - 1592

    

30. Local Low-Dose Thrombolysis for Safe and Effective Treatment of Venous Port-Catheter Thrombosis

    • Alexander Massmann
    • Philippe Jagoda
    • Arno Buecker

    Medical Oncology 07 October 2014 Pages: 1593 - 1597

    

31. Sex Differences in Melanoma Survival are Not Related to Mitotic Rate of the Primary Tumor

    • Arjen Joosse
    • Augustinus P. T. van der Ploeg
    • John F. Thompson

    Melanomas 19 November 2014 Pages: 1598 - 1603

32. Versatility of Percutaneous Pedicular Screw Fixation in Metastatic Spine Tumor Surgery: A Prospective Analysis

    • Naresh Kumar
    • Aye Sandar Zaw
    • Hee-Kit Wong

    Neuro-Oncology 25 October 2014 Pages: 1604 - 1611

    

33. Predictors of Prostate-Specific Antigen Biochemical Recurrence in Patients Undergoing Primary Whole-Gland Prostate Cryoablation

    • Yi Yang Liu
    • Po Hui Chiang
    • Hung Jen Wang

    Urologic Oncology 07 October 2014 Pages: 1612 - 1617

    

34. Are Urologists and Radiologists Equally Effective in Determining the RENAL Nephrometry Score?

    • Steeve Benadiba
    • Anne-Laure Verin
    • Jean-Jacques Patard

    Urologic Oncology 11 November 2014 Pages: 1618 - 1624

    

35. Extramammary Paget’s Disease in Males: Survival Outcomes in 495 Patients

    • Lindsey A. Herrel
    • Aaron D. Weiss
    • Viraj A. Master

    Urologic Oncology 11 November 2014 Pages: 1625 - 1630

    

36. Moving Fast and Moving Slow

    • Kiran K. Turaga
    • T. Clark Gamblin
    • David L. Bartlett

    Gastrointestinal Oncology 18 March 2015 Pages: 1631 - 1633

37. Peritoneal Surface Disease with Synchronous Hepatic Involvement Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

    • Reese W. Randle
    • Andrea N. Doud
    • Konstantinos I. Votanopoulos

    Regional Cancer Therapies 14 August 2014 Pages: 1634 - 1638

    

38. Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Patients with Diaphragmatic Involvement

    • Bernardo Franssen
    • Parissa Tabrizian
    • Umut Sarpel

    Gastrointestinal Oncology 13 September 2014 Pages: 1639 - 1644

    

39. Impact of Distal Pancreatectomy on Outcomes of Peritoneal Surface Disease Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Andrea N. Doud
    • Reese W. Randle
    • Konstantinos I. Votanopoulos

    Regional Cancer Therapies 14 August 2014 Pages: 1645 - 1650

    

40. A Comparative Analysis of Postoperative Pancreatic Fistulas After Surgery With and Without Hyperthermic Intraperitoneal Chemoperfusion

    • Stephanie Downs-Canner
    • Ying Ding
    • Haroon A. Choudry

    Gastrointestinal Oncology 28 October 2014 Pages: 1651 - 1657

    

41. Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

    • Maria F. Nunez
    • Armando Sardi
    • Vadim Gushchin

    Gastrointestinal Oncology 23 September 2014 Pages: 1658 - 1663

42. Intraperitoneal Chemotherapy at the Time of Surgery is Not Associated with Increased 30-Day Morbidity and Mortality Following Colorectal Resection

    • Edmund K. Bartlett
    • Rashikh A. Choudhury
    • Giorgos C. Karakousis

    Regional Cancer Therapies 15 August 2014 Pages: 1664 - 1672

    

43. Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies

    • Patricio M. Polanco
    • Ying Ding
    • Haroon A. Choudry

    Colorectal Cancer 07 November 2014 Pages: 1673 - 1679

    

44. Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent or Progressive Diffuse Malignant Peritoneal Mesothelioma: Clinicopathologic Characteristics and Survival Outcome

    • Chukwuemeka Ihemelandu
    • Lana Bijelic
    • Paul H. Sugarbaker

    Regional Cancer Therapies 14 August 2014 Pages: 1680 - 1685

    

45. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis

    • Joseph H. Helm
    • John T. Miura
    • Fabian M. Johnston

    Regional Cancer Therapies 15 August 2014 Pages: 1686 - 1693

    

46. Quality of Life After Isolated Limb Infusion for In-Transit Melanoma of the Extremity

    • Betty S. Jiang
    • Paul J. Speicher
    • Douglas S. Tyler

    Regional Cancer Therapies 14 August 2014 Pages: 1694 - 1700

    

47. Neutrophil–Lymphocyte Ratio is a Simple and Novel Biomarker for Prediction of Survival after Radioembolization for Metastatic Colorectal Cancer

    • Samer Tohme
    • Daniel Sukato
    • Allan Tsung

    Colorectal Cancer 05 September 2014 Pages: 1701 - 1707

    

48. Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures

    • Russell N. Low
    • Robert M. Barone
    • Janelle Lucero

    Gastrointestinal Oncology 09 September 2014 Pages: 1708 - 1715

    

49. Predictors of Progression in High-Grade Appendiceal or Colorectal Peritoneal Carcinomatosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Joel M. Baumgartner
    • Laura Tobin
    • Andrew M. Lowy

    Regional Cancer Therapies 22 August 2014 Pages: 1716 - 1721

    

50. Laparoscopic Evacuation of Mucinous Ascites for Palliation of Pseudomyxoma Peritonei

    • Kaitlyn J. Kelly
    • Joel M. Baumgartner
    • Andrew M. Lowy

    Gastrointestinal Oncology 14 November 2014 Pages: 1722 - 1725